We are live on ! Find out more
RCUS icon

Arcus Biosciences
RCUS

173 hedge funds and large institutions have $1.33B invested in Arcus Biosciences in 2022 Q2 according to their latest regulatory filings, with 53 funds opening new positions, 64 increasing their positions, 32 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 32

51% more first-time investments, than exits

New positions opened: 53 | Existing positions closed: 35

10% more funds holding

Funds holding: 157 → 173 (+16)

1.88% more ownership

Funds ownership: 71.25% → 73.13% (+1.9%)

16% less capital invested

Capital invested by funds: $1.59B → $1.33B (-$259M)

38% less funds holding in top 10

Funds holding in top 10: 8 → 5 (-3)

39% less call options, than puts

Call options by funds: $17.6M | Put options by funds: $28.9M

Holders
173
Holders Change
+16
Holders Change %
+10.19%
% of All Funds
2.91%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.08%
New
53
Increased
64
Reduced
32
Closed
35
Calls
$17.6M
Puts
$28.9M
Net Calls
-$11.3M
Net Calls Change
-$23.6M

Top Buyers

1
BlackRock
BlackRock
New York
+$97.5M
2
State Street
State Street
Massachusetts
+$41.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$18.9M
4
Goldman Sachs
Goldman Sachs
New York
+$17.8M
5
FC
Finepoint Capital
Massachusetts
+$13.1M

Top Sellers

1
EC
EcoR1 Capital
California
-$103M
2
AI
Alphabet Inc
California
-$80.9M
3
APM
Avidity Partners Management
Texas
-$28.8M
4
TCM
TimesSquare Capital Management
New York
-$25.9M
5
Franklin Resources
Franklin Resources
California
-$23.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
51
AlphaCrest Capital Management
New York
$3.2M +$3.09M +126,234 New
Millennium Management
52
Millennium Management
New York
$3.14M +$2.41M +98,303 +386%
CSS
53
Cubist Systematic Strategies
Connecticut
$2.94M +$1.65M +67,294 +138%
Squarepoint
54
Squarepoint
New York
$2.65M +$69K +2,819 +3%
Swiss National Bank
55
Swiss National Bank
Switzerland
$2.55M +$225K +9,200 +10%
Capital Fund Management (CFM)
56
Capital Fund Management (CFM)
France
$2.44M +$2.36M +96,224 New
BG
57
Bellevue Group
Switzerland
$2.28M -$529K -21,600 -19%
Public Sector Pension Investment Board (PSP Investments)
58
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.19M +$2.11M +86,296 New
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
$2.17M -$1.2M -49,024 -36%
PA
60
Parallel Advisors
California
$2.15M +$710 +29 +0%
Bank of America
61
Bank of America
North Carolina
$2.08M -$1.36M -55,473 -40%
UBS Group
62
UBS Group
Switzerland
$1.98M -$2.84M -115,801 -60%
New York State Teachers Retirement System (NYSTRS)
63
New York State Teachers Retirement System (NYSTRS)
New York
$1.87M +$1.81M +73,851 New
HS
64
HighVista Strategies
Massachusetts
$1.82M +$529K +21,600 +43%
First Trust Advisors
65
First Trust Advisors
Illinois
$1.79M +$459K +18,761 +36%
AQR Capital Management
66
AQR Capital Management
Connecticut
$1.78M +$1.72M +70,333 New
ECM
67
ExodusPoint Capital Management
New York
$1.76M +$970K +39,600 +133%
ECM
68
Endurant Capital Management
California
$1.64M +$639K +26,106 +68%
PCC
69
Park Circle Company
Maryland
$1.62M – – –
BNP Paribas Financial Markets
70
BNP Paribas Financial Markets
France
$1.62M +$1.31M +53,291 +509%
PIM
71
Platinum Investment Management
Australia
$1.57M – – –
Prudential Financial
72
Prudential Financial
New Jersey
$1.56M +$934K +38,140 +163%
California State Teachers Retirement System (CalSTRS)
73
California State Teachers Retirement System (CalSTRS)
California
$1.48M +$139K +5,686 +11%
Citadel Advisors
74
Citadel Advisors
Florida
$1.31M +$783K +31,975 +161%
UOC
75
UBS O'Connor
Illinois
$1.28M +$1.23M +50,425 New
1 2
3
4 5

RCUS Hedge Fund Activity: Q2 2022 in Review

173 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q2 2022, worth a combined $1.33B — down 16% from $1.59B a quarter earlier.

Buyers outnumbered sellers: 53 funds opened new RCUS positions and 35 closed out — a net gain of 18 holders — while 64 added to existing stakes and 32 trimmed.

The largest buyer was BlackRock, adding an estimated $97.5M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $103M sold.

  • 173 institutional investors held Arcus Biosciences (RCUS) as of Q2 2022, up from 157 in Q1 2022.
  • Funds reported $1.33B of Arcus Biosciences stock for Q2 2022, down 16% quarter-over-quarter.
  • 53 funds opened new Arcus Biosciences positions in Q2 2022 and 35 closed out, a net change of +18 holders.
  • The largest Arcus Biosciences buyer in Q2 2022 was BlackRock, an estimated $97.5M added.
  • The largest Arcus Biosciences seller in Q2 2022 was EcoR1 Capital, an estimated $103M sold.

Based on aggregated 13F filings for Q2 2022.